News | December 21, 2020

Empowering Pharma And Life Sciences Companies To Achieve Drug Development Breakthroughs With Advanced Analytics – Request A Free Pilot Project To Learn More About Quantzig's Analytics Capabilities


Quantzig, a premier data analytics and advisory firm, announces the launch of its comprehensive portfolio ofanalyticssolutions for the pharma and life sciences industry. Effective management of the vital information available to pharma and life sciences companies plays a crucial role in achieving breakthroughs in drug development and patient care. Hence, just like the healthcare industry, the pharma and life sciences industry must adopt analytics and leverage the insights to improve decision-making. Request a proposal to learn how our analytics solutions can help you make smarter, data-driven decisions to achieve operational excellence and drive performance.

This press release features multimedia. View the full release here:

The shift in focus towards patient centricity and the growing need to utilize the patient information available through various sources to improve drug formulations has given rise to several challenges for pharma and life sciences companies. At Quantzig, we understand these challenges and have developed industry-specific solutions to help our clients all along their transformation journey, right from strategy creation, opportunity identification, customer needs and market trends analysis, and portfolio optimization to revamp and benchmarking of business strategies.

Our analytics experts are equipped with the necessary skills and expertise to help our clients analyze data efficiently. We also enable pharma and life sciences companies to analyze their competition, develop comprehensive pricing strategies, and establish unparalleled business operations.

Stay ahead of the curve by leveraging our evidence-based analytics solutions. Contact usto know more.

Unlock New Treatment Pathways and Address Unmet Needs for Vaccines and Antivirals with Analytical Insights

Numerous growth opportunities lie hidden in data within the pharma and life sciences sector. But identifying and capitalizing on these opportunities is quite challenging, and those who succeed in doing so will gain a first-line advantage and the ability to move forward in their digital transformation journey. Quantzig possesses the cross-functional domain expertise and industry knowledge to help pharma companies find sticky revenue streams and discover new growth opportunities. Request for more information to gain comprehensive insights into our solution portfolio.

We aim to help our clients harness the true power of data to drive better outcomes across different segments within the pharma and life sciences industry, those involving patients, clinicians, providers, payers, medical researchers, and health regulators alike.

Quantzig’s advanced analytics solutions for the pharma and life sciences industry focuses on helping businesses in the following ways:

  • Leveraging data-driven insights to enhance drug development
  • Addressing unmet needs for vaccines and anti-virals
  • Expanding the digital footprint through newer service delivery models
  • Delivering meaningful insights to make fact-based decisions
  • Optimizing the innovation journey to achieve operational excellence

Request a FREE pilot to learn why leading pharma and life sciences companies leverage analytics to spot new trends and drive business growth.

About Quantzig

Quantzig is a global analytics and advisory firm with offices in the US, UK, Canada, China, and India. For more than 15 years, we have assisted our clients across industries with end-to-end data modeling capabilities to leverage analytics for prudent decision making. Today, our firm consists of 120+ clients, including 45 Fortune 500 companies. For more information on our engagement policies and pricing plans, visit:

Follow us on LinkedIn and Twitter to keep abreast of the latest innovation opportunities and analytics advancements impacting growth in the pharma and life sciences industry.

View source version on

Copyright Business Wire 2020